AzTrials
AzTrials

Hip OsteoarthritisNCT01857505

Hip Replacement in a High Volume Community Hospital: Effect on Length of Stay and Hospital Cost

An observational study of Hip Osteoarthritis, run by Anne Arundel Health System Research Institute at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The investigators propose to evaluate and compare the percentage of patients who are able to be discharged in less than 3 days after undergoing total hip arthroscopy through either a direct anterior or posterior approach, utilizing the identical post operative protocol. Read more about this study

Who is it for?
Ages 40 to 90 years
Conditions the study is for
Hip Osteoarthritis
How many people
0 participants
Where
1 siteUnited States
Study dates
Start not givento Jan 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who have undergone primary uncemented hip replacement at our institution (Anne Arundel Medical Center) through either a posterior approach or direct anterior approach on a fracture table utilizing the identical post operative protocol.

Who may be able to join

  • Consecutive single surgeon series of patients who have undergone primary uncemented hip replacement at our institution through either a posterior approach or direct anterior approach on a fracture table. Posterior approach patient - most recent patient prior to March, 2010, compared with consecutive recent anterior approach patients with minimum of 6 month follow-up.
  • Diagnosis of osteoarthritis, inflammatory arthritis, or avascular necrosis.
  • No previous surgery on affected hip.
  • Age 40-90 at time of surgery

Who cannot join

  • Patient not permitted to bear full weight after the procedure, per post operative instructions
  • Hip replacement performed for acute fracture.
  • Previous hip surgery.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Anne Arundel Medical Center

    Annapolis, Maryland, 21401

Other trials in United States

About this study

Official title: Introduction of the Direct Anterior Approach to Hip Replacement Into a High Volume Community Hospital: Effect on Length of Stay and Hospital Cost

The investigators propose to evaluate and compare the percentage of patients who are able to be discharged in less than 3 days after undergoing total hip arthroscopy through either a direct anterior or posterior approach, utilizing the identical post operative protocol. The investigators also propose to evaluate the costs associated with the two different approaches to hip replacement in the same group of patients. Post operative resource utilization, discharge disposition, and pain medicine requirement will also be evaluated.

Read the detailed description

The investigators hypothesize that a higher proportion of patients treated with the direct anterior approach for hip replacement will be able to leave the hospital in less than 3 days when compared with a less invasive posterior approach. Secondly, decreased length of stay associated with the procedure may reduce hospital costs.

Keywords
Total Hip replacement, Fracture table, DePuySynthes, Direct anterior approach hip replacement, Posterior approach hip replacement
Medical subject headings
Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01857505
Study groupRoleWhat they receive
Direct Anterior Approach hip replacementSingle surgeon series of 105 consecutive patients who underwent hip replacement via the direct anterior approach on a fracture table
Posterior Approach Hip Replacement105 consecutive patients previously operated on by a less invasive posterior approach at the same institution. These surgeries occurred prior to March, 2010.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of Hospital Stay

    The length of stay and proportion of patients who went home in less than 3 days will be determined for each group. To evaluate and compare the percentage of patients who are able to be discharged in less than 3 days after undergoing total hip arthroscopy through either a direct anterior or posterior approach, utilizing the identical post operative protocol.

    Measured: Retrospective review of hospital discharge records

  2. Hospital cost

    Hospital cost analysis will be undertaken for each group.

    Measured: Retrospective review of utilization records

Secondary outcomes (2)
  1. Post Operative Pain Medication Utilization

    Analysis of post operative pain medicine requirement will be compared for the two groups.

    Measured: After retrospective chart review is complete -- approximately 6 months

  2. Utilization of inpatient physical therapy resources

    Utilization of inpatient physical therapy resources and post hospital discharge disposition will be compared for the two groups.

    Measured: Retrospective review -- of hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2013 (estimated)
  2. Primary completionJan 2014

Why it stopped: Funding

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01857505
Sponsor's protocol ID
IIS-000158
Status last verified
Dec 2014
First submitted
10 May 2013
Last updated
18 Dec 2014
Results posted
No
Data monitoring committee
No

Publications

  • Hayes JH, Cleary R, Gillespie WJ, Pinder IM, Sher JL. Are clinical and patient assessed outcomes affected by reducing length of hospital stay for total hip arthroplasty? J Arthroplasty. 2000 Jun;15(4):448-52. doi: 10.1054/arth.2000.4346.

    PubMed 10884204
  • Vorhies JS, Wang Y, Herndon J, Maloney WJ, Huddleston JI. Readmission and length of stay after total hip arthroplasty in a national Medicare sample. J Arthroplasty. 2011 Sep;26(6 Suppl):119-23. doi: 10.1016/j.arth.2011.04.036. Epub 2011 Jul 1.

    PubMed 21723700
  • Duwelius PJ, Moller HS, Burkhart RL, Waller F, Wu Y, Grunkemeier GL. The economic impact of minimally invasive total hip arthroplasty. J Arthroplasty. 2011 Sep;26(6):883-5. doi: 10.1016/j.arth.2010.09.011. Epub 2010 Nov 3.

    PubMed 21051190
  • Matta JM, Ferguson TA. The anterior approach for hip replacement. Orthopedics. 2005 Sep;28(9):927-8. doi: 10.3928/0147-7447-20050901-11. No abstract available.

    PubMed 16190055
  • Matta JM, Shahrdar C, Ferguson T. Single-incision anterior approach for total hip arthroplasty on an orthopaedic table. Clin Orthop Relat Res. 2005 Dec;441:115-24. doi: 10.1097/01.blo.0000194309.70518.cb.

    PubMed 16330993

Questions about this trial

What is this clinical trial studying?

An observational study of Hip Osteoarthritis, run by Anne Arundel Health System Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 18 Dec 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of Hospital Stay (time frame: Retrospective review of hospital discharge records). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01857505, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in